Table V.
Association between PAK6 expression levels and clinicopathological parameters in cervical cancer.
| PAK6 expression levels (n) | ||||||
|---|---|---|---|---|---|---|
| Variable | Cases (n) | (−) | (+/++) | (+++) | Positive rate (%) | P-value |
| Age | >0.05 | |||||
| <45 | 21 | 3 | 13 | 5 | 85.71 | |
| ≥45 | 25 | 5 | 14 | 6 | 80.00 | |
| Pathological type | >0.05 | |||||
| Adenocarcinoma | 2 | 1 | 1 | 0 | 50.00 | |
| Adenosquamous carcinoma | 4 | 1 | 2 | 1 | 75.00 | |
| Squamous cell carcinoma | 40 | 6 | 24 | 10 | 85.00 | |
| International federation of gynecology and obstetrics stage | >0.05 | |||||
| I | 35 | 7 | 26 | 2 | 80.00 | |
| II | 8 | 1 | 1 | 6 | 87.50 | |
| III + IV | 3 | 0 | 0 | 3 | 100.00 | |
| Grade | <0.05 | |||||
| 1 | 6 | 4 | 2 | 0 | 33.33 | |
| 2 | 12 | 2 | 8 | 2 | 83.33 | |
| 3 | 22 | 0 | 14 | 8 | 100.00 | |
PAK6, p21-activated kinase 6.